NetScientific PLC is a life sciences and sustainability technology investment and commercialisation group
We leverage trans-Atlantic relationships and global opportunities to deliver shareholder value.
We look to maximise shareholder returns through focused execution of our investment strategy with current portfolio companies, and targeted investments in existing and new investment opportunities.
NetScientific develops a customized investment and realisation strategy for its portfolio companies.
We seek to enable the companies we work to access the right type of funding, proactive management support and resources specific to their sector, stage of development and available opportunities.
NetScientific is a holding company of its various technology businesses. It is not an AIM Investing Company

Our Subsidiaries and Portfolio

A Focus on Life Sciences, Technology, and Sustainability

Board and Management

Sector-specialist senior management team with extensive commercial experience.

Dr Ilian Iliev

Chief Executive Officer

John Clarkson

Executive Chairman

Clive Sparrow

Non-Executive Director

Professor Stephen Smith

Non-Executive Director

Stephen Crowe

Chief Financial Officer

News

NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine Versamune® T-cell activating platform demonstrates breadth of anti-SARS-CoV-2 immune responses in a COVID-19 vaccine   London, UK – 21 December 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, [...]
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited awarded Innovate UK grant to utilise company technology to identify high risk COVID-19 patients London, UK - 10 December 2020 - NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, announces that its portfolio company ProAxsis Limited ("ProAxsis"), announced that it has been awarded [...]
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Board changes and grant of Options   London, UK – 2 December 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation Group, is pleased to announce the planned strengthening of the Board in line with the stated strategy and shareholder circular from 6 [...]
NetScientific PLC: Life Sciences & Technology Investments